Otorhinolaryngologic Diseases  >>  Alvesco (ciclesonide)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
NCT00807053: Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)

Completed
2
480
US
Ciclesonide HFA, Placebo
AstraZeneca
Rhinitis, Allergic, Seasonal
06/07
07/07

Download Options